代谢组学
生物
代谢途径
胰岛素抵抗
糖尿病
烟酰胺
内科学
代谢控制分析
内分泌学
胰岛素
代谢组
多元分析
多元统计
代谢综合征
代谢物
生物化学
成对比较
碳水化合物代谢
新陈代谢
代谢适应
计算生物学
选择(遗传算法)
药品
葡萄糖稳态
表型
赖氨酸
糖耐量受损
生物信息学
遗传学
烟酰胺
药理学
作者
Zhulidezi Bahati,Runze Zou,Zhongda Zeng,Wei Duan
标识
DOI:10.1021/acs.jproteome.6c00446
摘要
Insulin resistance (IR) and impaired glucose regulation (IGR) involve metabolic disturbances beyond changes in blood glucose. This cross-sectional study applied untargeted UPLC-HRMS metabolomics to serum from 109 participants across normal glucose tolerance (NGT), IR, IGR, and type 2 diabetes mellitus (T2DM). An integrated analysis of 457 putatively annotated metabolites combined multivariate statistics, clustering, and machine learning to characterize differences among glycometabolic groups and assess the discriminatory information. Pairwise comparisons respectively identified 60, 42, and 59 differential metabolites for NGT vs IR, IR vs IGR, and IGR vs T2DM, including five shared across all comparisons. LASSO and random forest evaluated fixed differential-metabolite panels through stratified 5-fold cross-validation repeated ten times and 1,000 label permutations. The corresponding pooled AUC ranges were 0.918-0.923, 0.995-0.996, and 0.828-0.950. Because panel selection preceded cross-validation, these estimates describe within-cohort discrimination rather than generalizable predictive performance. Pathway analysis of the union of differential metabolites indicated nominal enrichment of lysine degradation and nicotinate and nicotinamide metabolism. Shared metabolites also showed associations with clinical measures of glucose homeostasis and insulin response. These findings characterize distinct yet partly shared metabolic features across glycometabolic states and provide candidates for targeted confirmation and independent longitudinal validation.
科研通智能强力驱动
Strongly Powered by AbleSci AI